NIH-funded research R01 grant

Understanding ADHD in children in Kenya and South Africa

Official title: 3/3 Akili: Phenotypic and genetic characterization of ADHD in Kenya and South Africa

Funded at University of Cape Town · NIH-11113911 · Data updated 2026-11-12

This project is gathering information from children with and without ADHD in Kenya and South Africa to better understand the disorder's causes and how it affects them.

More ADHD research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cape Town
NIH-funded
Lab location1 site (Rondebosch, South Africa)
Project startAugust 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$506,452
NIH project number5R01MH132950-03
Project IDNIH-11113911 on NIH RePORTER

Who could benefit from this research

Could help

Children aged 0-11 years in Kenya and South Africa, both those with a confirmed ADHD diagnosis and those without, are ideal candidates for this project.

Less likely to help

Patients seeking immediate treatment or direct therapeutic interventions for ADHD will not receive direct benefit from participating in this foundational research.

What this research studies

This project aims to learn more about Attention Deficit Hyperactivity Disorder (ADHD) by collecting detailed information from 6,000 children in Kenya and South Africa. Researchers will work with 4,000 children diagnosed with ADHD and 2,000 children without the condition. Each child will provide a DNA sample and complete various tests to understand their behavior, thinking skills, and overall health. This comprehensive approach helps us explore the genetic and behavioral aspects of ADHD in a diverse population.

Why it matters

Potential benefit: This work could help us better understand the biological roots of ADHD, how it varies among individuals, and its connections to other brain-related conditions, potentially leading to improved ways to help children with ADHD.

How similar studies have gone: While genetic studies of ADHD exist, this project is unique in its large scale and focus on diverse ancestral populations, addressing current gaps in global ADHD research.

Where this research is happening

  • University of Cape Town
    Rondebosch, South Africa
    Active

Researchers

  • Principal investigator: Donald, Kirsty — University of Cape Town
  • Study coordinator: Donald, Kirsty

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.